［1］ Lu H,Peng L,Yuan X,et al.Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma:a treatment paradigm also applicable to patients in Southeast Asia ［J］.Cancer Treat Rev,2009,35:345-353.
[2] Gao Y,Zhu G,Lu J,et al.Is elective irradiation to the lower neck necessary for N0 nasopharngeal carcinoma ［J］.Int J Radiat Oncol Biol Phys,2010,77:1397-1402.
[3] Posner MR,Hershock DM,Blajman CR，et al.Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer ［J］.N Engl J Med,2007,357(17):1705-1715.
[4] Hellberg V,Wallin I,Eriksson S，et al.Cisplatin and oxaliplatin toxicity:importance of cochlear kinetics as a determinant for ototoxicity ［J］.J Natl Cancer Inst,2009,101(1):37-47.
[5] Hitchcock YJ,Tward JD,Szabo A，et al.Relative contribution of radiotherapy and cisplatin-based chemotherapy to sensori-neural hearing loss in head and neck cancer patients ［J］.Int J Radiat Oncol Biol Phys,2009,73(3):779-788.
[6] Low WK,Toh ST,Wee J，et al.Sensori-hearing loss after chemotherapy and radiochemotherapy ［J］.J Clin Oncol,2006,24 (12):1904-1909.
[7] Hellberg V,Wallin I,Eriksson S，et al.Cisplatin and Oxaloplatin toxicity:importance of cochlea kinetics as a determinant for ototoxicity ［J］.J Natl Cancer Inst,2009,101(1):37-47.
[8] Rademaker-Lakhai JM,Crul M,Zuur L,et al.Relationship between cisplatin administration and the development of ototoxicity ［J］.J Clin Oncol,2006,24(6):918-924.
[9] Chen WC,Jackson A,Budnick AS，et al.Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma ［J］.Cancer,2006,106(4):820-829.
[10] Petsuksiri J,Sermsree A,Thephamongkhol K，et al.Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients ［J］.Radiat Oncol,2011，20(2):6-19.
[11] Chan SH,Ng WT,Kam KL,et al.Sensorineural hearing loss after treatment of nasopharyngeal carcinoma:a longitudinal analysis ［J］.Int J Radiat Oncol Biol Phys,2009,73(5):1335-1342.
[12] Chen WC,Jackson A,Budnick AS，et al.Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma ［J］.Cancer,2006,106(4):820-829.
[13] Yilmaz YF,Aytas FI,Akdogan O,et al.Sensorineural hearing loss after radiotherapy for head and neck tumors:a prospective study of the effect of radiation［J］.Otol Neurotol,2008,29(4):461-463.
[14] Kodaira T,Tomita N,Tachibana H,et al.Aichi cancer center initial experience of intensity modulated radiation therapy for nasopharyngeal cancer using helical tomotherapy ［J］.Int J Radiat Oncol Biol Phys,2009，73(4):1129-1134.
[15] Yan M,Lovelock D,Hunt M，et al.Measuring uncertainty in dose delivered to the cochlea due to setup error during external beam treatment of patients with cancer of the head and neck ［J］.Med Phys,2013,40(12):121-127.
[16] Nguyen NP,Smith-Raymond L,Vinh-Hung V,et al.Feasibility of Tomotherapy to spare the cochlea from excessive radiation in head and neck cancer ［J］.Oral Oncol,2011，47(5):414-419.
[17] Marks LB,Yorke ED,Jackson A，et al.Use of normal tissue complication probability models in the clinic ［J］.Int J Radiat Oncol Biol Phys,2010,76(3):10-19.
[18] Jiang Chaoyang，Zhang Ling，Pan Xingguo，et al.The evaluation of the cochlea in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy［J］.Modern Oncology,2014,22(8):1801-1804.［蒋朝阳,张伶,潘兴国,等.鼻咽癌调强放疗中耳蜗受量评价［J］.现代肿瘤医学,2014,22(8):1801-1804.］
[19] Lee VH,Ng SC,Leung TW，et al.Dosimetric predictors of radiation-induced acute nausea and vomiting in IMRT for nasopharyngeal cancer ［J］.Int J Radiat Oncol Biol Phys,2012,84(1):176-182.
[20] Koshy AN,Briggs RJ,Dally M，et al.Primary melanoma of the cochlea with cerebellopontine extension and leptomeningeal spread ［J］.J Laryngol Otol,2014,2(19):1-4.
[21] Anderson BM,Khuntia D,Bentzen SM，et al.Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery［J］.J Neurooncol,2014,116(1):187-193.
[22] Sager O,Beyzadeoglu M,Dincoglan F，et al.Management of vestibular schwannomas with linear accelerator-based stereotactic radiosurgery:a single center experience ［J］.Tumori,2013,99(5):617-622.
[23] Jiang Chaoyang，Zhang Ling，Pan Xingguo，et al.Radiation dose to the internal auditory canal in advanced nasopharyngeal carcinoma treated with intensity-modulated radiation therapy ［J］.Modern Oncology,2016,24(5):809-812.［蒋朝阳,张伶,潘兴国,等.晚期鼻咽癌调强放疗中内耳道受量评价［J］.现代肿瘤医学,2016,24(5):809-812.］